-
Oct 20, 2022, 09:59 AM
by
END
Contact information
For media enquiries, please contact Imogen Quail, PR Manager, at ramarketing: imogen.quail@ramarketingpr.com, +44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr, LinkedIn: /ramarketing
About Recipharm
Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden.
For more information on Recipharm and our services, please visit www.recipharm.com
1Source Safety Prefilled Syringe Market Size is expected to reach (globenewswire.com)
Recipharm AB
Corporate identity number 556498-8425
Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00
www.recipharm.com
Full story
-
Oct 20, 2022, 09:59 AM
by
Full story
-
Oct 20, 2022, 09:58 AM
by
CD BioSciences recently announced the launch of a comprehensive panel of research solutions covering all aspects of cell death study.
Full story
-
Oct 20, 2022, 09:55 AM
by
Amerigo Scientific recently announced the launch of its new polyclonal antibody to human blood coagulation factor XIII for the detection of blood coagulation factor XIII.
Full story
-
Oct 20, 2022, 09:51 AM
by
STEMart has recently introduced Biological Indicator Sterility Testing services for the industry of medical devices.
Full story
-
Oct 20, 2022, 09:51 AM
by
Creative Diagnostics recently introduced Fluorometric Neuraminidase Assay services to the global research community.
Full story
-
Oct 20, 2022, 09:50 AM
by
Integration Identifies Members’ Needs, Helps Guide Home Healthcare Delivery
Full story
-
Oct 20, 2022, 09:46 AM
by
A robust telomere aging clocks system combined with RF, qPCR, STELA, and TESLA techniques is newly reconfigured to conduct specialized lab-grade telomere length analysis and offer comprehensive pictures of biological aging.
Full story
-
Oct 20, 2022, 08:00 AM
by
User Not Found
Bio-IT World | At the Bio-IT World Conference & Expo Europe yesterday, Evotec SE launched the first commercial version of its PanOmics data analysis platform PanHunter. PanHunter is Evotec’s PanOmics data access and analytics platform and was developed and used successfully internally and in industry-shaping drug discovery partnerships over many years. Evotec now makes PanHunter available to collaborators and partners as a software-as-a-service (“SaaS”) product.
Full story
-
Oct 20, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Bio-IT World has announced the winner of the first Bio-IT World Europe Best of Show Awards. Among finalists from Dassault Systèmes BIOVIA, Evotec, The Hyve, Ontoforce, and Quilt Data, MemVerge was named the Best of Show People’s Choice winner.
Full story
-
Oct 19, 2022, 16:03 PM
by
Full story
-
Oct 19, 2022, 15:52 PM
by
Form Bio is a new, cutting-edge research and discovery platform for individuals and enterprises in life sciences. With the most accessible, comprehensive and collaborative platform in the field, Form Bio empowers scientists to efficiently and effectively harness the proliferation of data and computing power that has transformed the science of discovery. Form offers end-to-end integration of the discovery process with intuitive and easy-to-use software applications, combined with an open and adaptable collaborative environment. Form Bio was developed within Colossal Biosciences and co-founded by Ben Lamm, Andrew Busey, and Kent Wakeford. For more information on Form Bio, please visit www.formbio.com
Full story
-
Oct 19, 2022, 15:52 PM
by
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today it has successfully renewed its ISO 27001 certification (Information Security Management System) and obtained ISO 27017 certification (Information Security in cloud services) and ISO 37001 certification (Anti-bribery management systems).
Full story
-
Oct 19, 2022, 15:52 PM
by
Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide.
Full story
-
Oct 19, 2022, 15:52 PM
by
New functionality added to advanced dossier management solution to bring greater efficiencies to eCTD compliance
Full story
-
Oct 19, 2022, 15:52 PM
by
A ribbon-cutting ceremony was held on Thursday, October 13 to celebrate the achievement of Purolite, an Ecolab company’s increased bioprocessing resin production to meet the growing demand for biopharmaceutical products globally.
Full story
-
Oct 19, 2022, 15:51 PM
by
Creative Peptides announces to provide ready-to-ship Fmoc-Tyr(HP03Bzl)-OH products with 90% and 95% purities, which can be ordered in small amounts or large scale according to client demand.
Full story
-
Oct 19, 2022, 15:51 PM
by
Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe.
Full story
-
Oct 19, 2022, 15:51 PM
by
BiologicsMD, a preclinical therapeutic development company focused on highly-targeted treatments for hair loss and bone disorders, announced today the appointment of Brett King, MD, PhD, Associate Professor of Dermatology at Yale Medical School, as a Senior Scientific Advisor to the company’s management team and Board of Directors.
Full story
-
Oct 19, 2022, 15:51 PM
by
Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility in Alnwick, UK.
Full story